Insilico Partners with SK Biopharmaceuticals in $2.5B AI Drug Pact
Insilico Medicine has partnered with SK Biopharmaceuticals in a significant $2.5 billion agreement focused on AI-driven drug discovery.
Results for "Insilico Medicine"
6 stories found
Eli Lilly Expands AI Drug Discovery Partnership with Insilico Medicine
Eli Lilly is deepening its commitment to artificial intelligence in drug discovery by expanding its existing partnership with Insilico Medicine.
Insilico Medicine and Human Longevity Partner on AI Disease Prediction Models
Hong Kong-listed AI drug-discovery company Insilico Medicine has announced a collaboration with US-headquartered Human Longevity to co-develop large-scale AI foundation models aimed at predicting diseases decades in advance.
HealthReutersbloombergwsj+8FTcnbcberlingskeSCMPpolitikennaftemporikichannel-news-asiaseeking-alpha2mo ago11 sources
Eli Lilly Finalizes $2.75 Billion AI Drug Discovery Deal with Insilico Medicine
Global pharmaceutical company Eli Lilly has finalized a $2.75 billion agreement to expand its partnership with Insilico Medicine, licensing an early-stage drug pipeline and utilizing Insilico's artificial intelligence platform for drug development to bring AI-developed medicines to market, with new reports confirming the deal.
Insilico Taps US Partner to Develop AI Model for Human Longevity
Insilico Medicine has partnered with a US firm to develop an artificial intelligence model aimed at advancing research into human longevity.
Insilico Medicine Partners with UAE for AI Drug Discovery
Hong Kong-listed Insilico Medicine has signed a cooperation agreement with the United Arab Emirates' drug regulator to advance the use of its AI tools in drug discovery across the region.